EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clonal Hematopoiesis and therapy related MDS/AML

Pinkal Desai, Gail J Roboz

Best Practice & Research Clinical Haematology · 2019-03 · 32 (1) · 13-23

DOI: 10.1016/j.beha.2019.02.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Haematology, 2019-03. Verfasst von Pinkal Desai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology & Oncology, Weill Cornell Medicine, New York, NY, USA. Electronic address: pid9006@med.cornell.edu. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Leukemia, Myeloid, Acute, Mutation, Myelodysplastic Syndromes. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 72 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal Hematopoiesis is defined as the presence of mutations in peripheral blood in the absence of myeloid malignancies and is thought to occur as a normal part of ageing due to the fitness advantage conferred by these mutations in an ageing hematopoietic compartment. Therapy related myeloid neoplasms are malignancies that occur after exposure to chemotherapy/radiation and are associated with poor survival. Clonal hematopoiesis mutations represent a pre malignant state that can be triggered by exposure to cytotoxic damage and rapid hematopoietic stem cell expansion. We discuss in this review clinical evidence of association of clonal hematopoiesis with risk of therapy related myeloid neoplasms, the underlying mechanisms of clonal expansion under different cellular stresses and recommendations on clinical follow up of patients with clonal hematopoiesis including possible strategies for prevention of therapy related myeloid neoplasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem CellsLeukemia, Myeloid, AcuteMutationMyelodysplastic SyndromesNeoplasms, Second PrimaryHematopoiesisHumans

Stichwörter der Autor:innen

ARCHCHIPClonal hematopoiesisTherapy related MDS/AMLTherapy related myeloid neoplasm

Autor:innen und Institutionen

  • Division of Hematology & Oncology, Weill Cornell Medicine, New York, NY, USA. Electronic address: pid9006@med.cornell.edu.
  • Division of Hematology & Oncology, Weill Cornell Medicine, New York, NY, USA.

Zitieren

APA

Desai, P., & Roboz, G. J. (2019). Clonal Hematopoiesis and therapy related MDS/AML. Best Practice & Research Clinical Haematology, 32(1), 13-23. https://doi.org/10.1016/j.beha.2019.02.006

Vancouver

Desai P, Roboz GJ. Clonal Hematopoiesis and therapy related MDS/AML. Best Practice & Research Clinical Haematology. 2019;32(1):13-23. doi:10.1016/j.beha.2019.02.006

BibTeX
@article{Desai2019,
  author = {Desai, Pinkal and Roboz, Gail J},
  title = {Clonal Hematopoiesis and therapy related MDS/AML},
  journal = {Best Practice & Research Clinical Haematology},
  year = {2019},
  volume = {32},
  number = {1},
  pages = {13--23},
  doi = {10.1016/j.beha.2019.02.006}
}
Kostenlos starten →